Source: International Congress 2018 – Chronic thromboembolic pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Edemskiy (Novosibirsk, Russian Federation), A. Chernyavskiy (Novosibirsk, Russian Federation), B. Rudenko (Moscow, Russian Federation), N. Novikova (Novosibirsk, Russian Federation), A. Romanov (Novosibirsk, Russian Federation). Pulmonary denervation is a new alternative non-pharmacological treatment for residual pulmonary hypertension after pulmonary endarterectomy. 4941

Member's Comments

No comment yet.

Related content which might interest you: Exercise-induced pulmonary hypertension in patients after successful pulmonary endarterectomy Source: Eur Respir J 2006; 28: Suppl. 50, 401s Year: 2006 Pulmonary endarterectomy: the potentially curative treatment for patients with chronic thromboembolic pulmonary hypertension Source: Eur Respir Rev 2015; 24: 263-271 Year: 2015 Pulmonary endarterectomy in the management of chronic thromboembolic pulmonary hypertension Source: Eur Respir Rev 2017; 26: 160111 Year: 2017 Effects of sildenafil as a bridge therapy for pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018 Surgical and post-operative treatment of chronic thromboembolic pulmonary hypertension Source: Eur Respir Rev 2009; 19: 64-67 Year: 2010 Surgical treatment of chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2013; 41: 735-742 Year: 2013 Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension with distal lesions Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers Year: 2013 Medical treatment in persistent pulmonary hypertension after pulmonary thrombendarterectomy in patients with chronic thrombembolic pulmonary hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 364s Year: 2006 Influence of discontinuation of medication after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension Year: 2016 Persistent exercise intolerance after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension Source: Eur Respir J, 55 (6) 2000109; 10.1183/13993003.00109-2020 Year: 2020 MRI-derived regional pulmonary perfusion and cardiac function for monitoring patients with chronic thromboembolic pulmonary hypertension before and after pulmonary endarterectomy Source: International Congress 2015 – CT, PET, MRI modalities: fusion of anatomical and functional variables for lung assessment Year: 2015 Pulmonary rehabilitation in patients with pulmonary arterial hypertension Source: ERS Course 2017 Year: 2017 Current medical treatment of pulmonary arterial hypertension Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease Year: 2018 Current medical treatment of pulmonary arterial hypertension Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease Year: 2017 Current medical treatment of pulmonary arterial hypertension Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease Year: 2012 Current medical treatment of pulmonary arterial hypertension Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease Year: 2014 Update on current treatment options of pulmonary hypertension Source: Annual Congress 2006 - Pulmonary hypertension at the crossroads of science and clinical medicine Year: 2006 Multi-step therapy with riociguat, balloon pulmonary angioplasty, and cardiac rehabilitation for inoperable chronic thromboembolic pulmonary hypertension Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension Year: 2017 The future of treatment for pulmonary arterial hypertension Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease Year: 2014